GARDP Webinar: How can non-profit drug developers counter AMR?

  27 April 2023

Antibiotics underpin modern medicine and are critical for pandemic preparedness. The aim of the webinar is to highlight the value of the nonprofit R&D business model in tackling antimicrobial resistance (AMR). It will look at the importance of public-private partnerships, such as GARDP, in accelerating the development and access to new and improved treatments for drug-resistant infections.  The webinar will feature experts who have been deeply involved in the non-profit public health sector and are committed to introducing new health treatments for priority public health needs.

We will be joined by:

Laura Piddock, Scientific Director, GARDP

Pietro Turilli, Senior Vice President, External Affairs, TB Alliance

Monique Wasunna, Director, DNDi Eastern Africa

Moderated by: Claire Doole

More information is available on our website: https://gardp.org/events/webinar-how-can-a-nonprofit-drug-development-model-counter-amr/

The registration link is available here: Register here

Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed